Strong target candidate with converging metabolic, structural and chemical evidence.
Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.
Main supporting evidence
Terms and data sources used on this page
PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.
AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.
ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.
pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.
FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.
Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.
PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.
ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.
ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.
LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.
Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.
DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.
Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.
EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.
KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.
Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.
Prioritization evidence
Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.
Off-target risk
- Human off-target
- No hit
- Gut microbiome similarity
- 3.8% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.
Essentiality
- Essential (DEG)
- N
- DEG identity (%)
- 0.0 Higher values support similarity to known essential genes.
Localization
- Localization
- CytoplasmicMembrane
Structure confidence
- ColabFold pLDDT
- 95.06 0-100 confidence; >70 supports local structural interpretation.
Binding-site evidence
AlphaFold DB / UniProt modelThe selected pocket score is the FPocket value used for ranking after applying the curated structure priority. It estimates small-molecule pocket quality; it is not experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.
Cross-references
External database identifiers for this protein, its structures, ligands, and metabolic reactions.
Sequence
Sequence
Primary amino-acid sequence viewer.
MITIDGNGAVASVAFRTSEVIAIYPITPSSTMAEQADAWAGNGLKNVWGDVPRVVEMQSEAGAIGAVHGALQTGALSTSFTSSQGLLLMIPTLYKLAGQLMPFVLHVAARTVATHALSIFGDHSDVMAVRQTGCAMLCASSVQEAQDFALISHIATLQSRVPFIHFFDGFRTSHEINKIAPLADDTIRALLPQDKIAEHRQRALNPEHPVIRGTSANPDTYFQSREATNPWYDAVYDHVEKAMDDFAAATGRQYKPFEFYGHPQAERVIVIMGSAIGTCEEVVDELLSRGEKVGVLKVRLYRPFSAAHLLAALPESARAVAVLDRTKEPGALAEPLYLDVMTALAEAFNRGERETLPRTIGGRYGLSSKEFGPECVLAIFSELQAAQPKPRFTVGIYDDVTNLSLPLGENTLPAEAKLEALFYGLGSDGSVSATKNNIKIIGNSTPWFSQGYFVYDSKKAGGLTVSHLRVSEKPIRSSYLISQADFVGCHQLQFIDKYQMAERLKPGGIFLLNTPYSAVEVWSRLPQEVQATLNQKKARFYVVNAAKIARECSLGARINTVMQMAFFHLTQILPGDSALAELQAAIAKSYSSKGQELVERNWQALALARESLAEVPLQPVNASSPNRPPVVSDAAPDFVKTVTAAMLAGLGDALPVSALPPDGTWPMGTTRWEKRNIAEEIPIWKEALCTQCNHCVAACPHSAIRAKVVAPEEMENAPASLHSLDVKSRDMRGQKYVLQVAPEDCTGCNLCVEVCPAKDRQNPEIKAINMMSRLEHVEEEKVNYEYFLNLPEIDRSKLERIDIRTSQLISPLFEYSGACSGCGETPYIKLLTQLYGDRMLIANATGCSSIYGGNLPSTPYTTDANGRGPAWANSLFEDNAEFGLGFRLTVDQHRQRVMRLLSEFADKLPVELNAALHAEATPEVRREQVAALRQALAGVAGAEELLTDADALVEKSVWLIGGDGWAYDIGFGGLDHVLSLTENVNILVLDTQCYSNTGGQASKATPLGAVTKFGEHGKRKARKDLGVSMMMYGHVYVAQISLGAQLNQTVKAIQEAEAYPGPSLIIAYSPCEEHGYDLALSHDQMRQLTATGFWPLYRFDPRRADEGKIPLALDSRPPSDALAETLLNEQRFRRLNAQQPEVAEQLWKDAAADLQKRYDFLAQLAGKAEKSPSEG
Functional annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Enzyme Commission (EC)
1Gene Ontology (GO)
8- GO:0030976 Binding to thiamine pyrophosphate, the diphosphoric ester of thiamine. Acts as a coenzyme of several (de)carboxylases, transketolases, and alpha-oxoacid dehydrogenases.
- GO:0022900 A process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors.
- GO:0016903 Catalysis of an oxidation-reduction (redox) reaction in which an aldehyde or ketone (oxo) group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
- GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
- GO:0005506 Binding to an iron (Fe) ion.
- GO:0003824 Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
- GO:0051539 Binding to a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.
- GO:0006979 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
Sequence domains and features
Domain and signature matches imported from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 736 | 765 | ProSiteProfiles | PS51379 | 4Fe-4S ferredoxin-type iron-sulfur binding domain profile. |
| 736 | 765 | InterPro | IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain |
| 631 | 668 | Gene3D | G3DSA:4.10.780.10 | - |
| 631 | 668 | InterPro | IPR037112 | Pyruvate-flavodoxin oxidoreductase, EKR domain superfamily |
| 669 | 791 | Gene3D | G3DSA:3.30.70.20 | - |
| 680 | 709 | ProSiteProfiles | PS51379 | 4Fe-4S ferredoxin-type iron-sulfur binding domain profile. |
| 680 | 709 | InterPro | IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain |
| 6 | 169 | CDD | cd07034 | TPP_PYR_PFOR_IOR-alpha_like |
| 6 | 169 | InterPro | IPR002880 | Pyruvate flavodoxin/ferredoxin oxidoreductase, pyrimidine binding domain |
| 2 | 254 | SUPERFAMILY | SSF52518 | Thiamin diphosphate-binding fold (THDP-binding) |
| 2 | 254 | InterPro | IPR029061 | Thiamin diphosphate-binding fold |
| 665 | 838 | SUPERFAMILY | SSF54862 | 4Fe-4S ferredoxins |
| 1 | 1164 | PANTHER | PTHR32154 | PYRUVATE-FLAVODOXIN OXIDOREDUCTASE-RELATED |
| 255 | 414 | Gene3D | G3DSA:3.40.50.920 | - |
| 255 | 414 | InterPro | IPR009014 | Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II |
| 419 | 668 | SUPERFAMILY | SSF53323 | Pyruvate-ferredoxin oxidoreductase, PFOR, domain III |
| 419 | 668 | InterPro | IPR002869 | Pyruvate-flavodoxin oxidoreductase, central domain |
| 1 | 1165 | NCBIfam | TIGR02176 | pyruvate:ferredoxin (flavodoxin) oxidoreductase |
| 1 | 1165 | InterPro | IPR011895 | Pyruvate-flavodoxin oxidoreductase |
| 1 | 1174 | PIRSF | PIRSF000159 | NifJ |
| 1 | 1174 | InterPro | IPR011895 | Pyruvate-flavodoxin oxidoreductase |
| 417 | 623 | Gene3D | G3DSA:3.40.920.10 | - |
| 417 | 623 | InterPro | IPR002869 | Pyruvate-flavodoxin oxidoreductase, central domain |
| 1 | 254 | Gene3D | G3DSA:3.40.50.970 | - |
| 689 | 757 | Pfam | PF12838 | 4Fe-4S dicluster domain |
| 689 | 757 | InterPro | IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain |
| 1 | 254 | FunFam | G3DSA:3.40.50.970:FF:000012 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 426 | 610 | Pfam | PF01558 | Pyruvate ferredoxin/flavodoxin oxidoreductase |
| 426 | 610 | InterPro | IPR019752 | Pyruvate/ketoisovalerate oxidoreductase, catalytic domain |
| 811 | 1166 | CDD | cd03377 | TPP_PFOR_PNO |
| 794 | 1167 | Gene3D | G3DSA:3.40.50.970 | - |
| 669 | 791 | FunFam | G3DSA:3.30.70.20:FF:000022 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 794 | 1166 | SUPERFAMILY | SSF52518 | Thiamin diphosphate-binding fold (THDP-binding) |
| 794 | 1166 | InterPro | IPR029061 | Thiamin diphosphate-binding fold |
| 255 | 411 | SUPERFAMILY | SSF52922 | TK C-terminal domain-like |
| 255 | 411 | InterPro | IPR009014 | Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II |
| 622 | 679 | SMART | SM00890 | EKR_2 |
| 622 | 679 | InterPro | IPR019456 | Pyruvate-flavodoxin oxidoreductase, EKR domain |
| 265 | 347 | Pfam | PF17147 | Pyruvate:ferredoxin oxidoreductase core domain II |
| 265 | 347 | InterPro | IPR033412 | Pyruvate:ferredoxin oxidoreductase, core domain II |
| 13 | 243 | Pfam | PF01855 | Pyruvate flavodoxin/ferredoxin oxidoreductase, thiamine diP-bdg |
| 13 | 243 | InterPro | IPR002880 | Pyruvate flavodoxin/ferredoxin oxidoreductase, pyrimidine binding domain |
| 255 | 413 | FunFam | G3DSA:3.40.50.920:FF:000007 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 631 | 668 | FunFam | G3DSA:4.10.780.10:FF:000001 | Probable pyruvate-flavodoxin oxidoreductase |
| 626 | 678 | Pfam | PF10371 | Domain of unknown function |
| 626 | 678 | InterPro | IPR019456 | Pyruvate-flavodoxin oxidoreductase, EKR domain |
| 745 | 756 | ProSitePatterns | PS00198 | 4Fe-4S ferredoxin-type iron-sulfur binding region signature. |
| 745 | 756 | InterPro | IPR017900 | 4Fe-4S ferredoxin, iron-sulphur binding, conserved site |
| 794 | 1167 | FunFam | G3DSA:3.40.50.970:FF:000047 | Probable pyruvate-flavodoxin oxidoreductase |
| 416 | 626 | FunFam | G3DSA:3.40.920.10:FF:000001 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 936 | 1066 | Pfam | PF02775 | Thiamine pyrophosphate enzyme, C-terminal TPP binding domain |
| 936 | 1066 | InterPro | IPR011766 | Thiamine pyrophosphate enzyme, TPP-binding |
3D structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.
How colors and pocket overlays are used
Pocket details Inspect a specific pocket, or open the full viewer
- Method
- -
- Score
- -
- Visible layer
- -
- Residues
- -
- Pocket properties
- -
Selecting a pocket opens its details and centers the viewer without clearing other active layers. Use Focus this pocket when you want to hide the rest; use Surface for the wider residue environment.
Binding pockets · FPocket
Druggability: high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Binding pockets · P2Rank
Probability: high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Residue sets
Binding pockets · FPocket
Druggability: high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Binding pockets · P2Rank
Probability: high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
All structural evidence
Structural evidence
0 + 2Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold DB
AF_A0A0H3GSL1
|
AlphaFold DB | — | — | full sequence | — | Viewing |
|
ColabFold
KP13_05584
|
ColabFold | — | — | full sequence | — | Loaded |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Structural ligand evidence is available for this target.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in Target, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| 5SR RCSB PDB | Q2RI41 | 468.3 Da LogP -0.09 TPSA 209.1 | ✓ Ro5 | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)C(=O)O)CCOP(=O)(O)OP…
|
|
| CO2 RCSB PDB | P94692 | 44.0 Da LogP -0.58 TPSA 34.1 | ✓ Ro5 | ✓ Clean |
C(=O)=O
|
|
| HTL RCSB PDB | P94692 | 467.4 Da LogP 1.04 TPSA 186.0 | ✓ Ro5 | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)C(=O)C)CCO[P@@](=O)(…
|
|
| O2T RCSB PDB | Q2RI41 | 514.3 Da LogP -1.57 TPSA 249.6 | 3 viol. | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)C(C(=O)O)(O)O)CCOP(=…
|
|
| PYR RCSB PDB | P94692 | 88.1 Da LogP -0.34 TPSA 54.4 | ✓ Ro5 | ✓ Clean |
CC(=O)C(=O)O
|
|
| TDL RCSB PDB | Q2RMD6 | 513.4 Da LogP 0.13 TPSA 226.5 | 2 viol. | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)[C@](C)(C(=O)O)O)CCO…
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
| Ligand | Tanimoto | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|
| ZINC8215517 ZINC | 0.656 | 425.3 Da LogP 0.84 TPSA 169.0 | ✓ Ro5 | ✓ Clean |
Cc1ncc(C[n+]2csc(CCO[P@@](=O)(O)OP(=O)(O)O)c2C)…
|
| ZINC1532839 ZINC | 0.522 | 345.3 Da LogP 0.72 TPSA 122.4 | ✓ Ro5 | ✓ Clean |
Cc1ncc(C[n+]2csc(CCOP(=O)(O)O)c2C)c(N)n1
|
| ZINC13540298 ZINC | 0.507 | 440.3 Da LogP 0.72 TPSA 187.1 | ✓ Ro5 | ✓ Clean |
Cc1ncc(Cn2c(C)c(CCO[P@@](=O)(O)OP(=O)(O)O)sc2=O…
|
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.